Bolt Biotherapeutics vs Connect Biopharma
BOLT and CNTB side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BOLT and CNTB compare
Connect Biopharma grew revenue faster over the last twelve months (50.3% versus 12.8% for Bolt Biotherapeutics).
Bolt Biotherapeutics keeps more of each dollar of sales as profit, with a net margin of −611% compared with −2336% at Connect Biopharma.
Bolt Biotherapeutics scores higher on the StockData Score (11 against 6 for Connect Biopharma), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BOLT | CNTB |
|---|---|---|
| Size and price | ||
| Market cap | $12.1M | – |
| Share price | $6.26 | $0.689 |
| Change, 1 year | 27.2% | −54.7% |
| Change, 5 years | −96.4% | −86.5% |
| Beta (5Y) | 0.63 | 0.53 |
| Employees | 23 | – |
| StockData Score | ||
| Total score | 11 (better) | 6 |
| Valuation score | 3 (better) | 0 |
| Growth score | 2 (better) | 1 |
| Performance score | 1 (better) | 0 |
| Health score | 5 | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 2.6× | – |
| P/B | 1.0× | – |
| Fair value | $9.05 | – |
| Margin of safety | 30.9% | – |
| Growth | ||
| Revenue growth (TTM) | 12.8% | 50.3% (better) |
| Revenue growth, 5Y average | 102% | – |
| Profitability | ||
| Operating margin | −655% (better) | −2384% |
| Net margin | −611% (better) | −2336% |
| FCF margin | – | −2053% |
| Return on equity | −112% (better) | −141% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 2.61 (better) | 2.37 |
| Altman Z-score | −18.27 | – |
| Piotroski F-score | 5 (better) | 1 |
| Dividends and buybacks | ||
| Buyback yield | −0.25% | – |
| Shareholder yield | −0.25% | – |
| Ownership | ||
| Held by institutions | 31.0% | 22.1% |
| Held by insiders | 12.2% | 31.6% |
| Insider net buying, 12 months | $196K | $4.4M (better) |
| Short interest, % of float | 2.8% | – |
Go deeper
- BOLT stock overview
- BOLT income statement
- BOLT valuation and score
- CNTB stock overview
- CNTB income statement
- CNTB valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.